Our data, therefore suggest that for observing the function of RIPK3 on tumor suppression, especially thymic lymphoma, the effects on tumor development are more easily observed in a tumor‐prone genetic background, with a long‐term in vivo model analysis method. The gene discussed is RIPK3; the disease is neoplasm.